{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T22:44:58Z","timestamp":1782773098725,"version":"3.54.5"},"reference-count":42,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Monoclonal Antibodies in Immunodiagnosis &amp; Immunotherapy"],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:p>\n                    CC chemokine receptor 6 (CCR6) is a member of the G-protein-coupled receptor family that is highly expressed in B lymphocytes, effector and memory T cells, regulatory T cells, and immature dendritic cells. CCR6 has been revealed to have important functions in many pathological conditions, such as cancer, intestinal bowel disease, psoriasis, and autoimmune diseases. The only CCR6 chemokine ligand, CC motif chemokine ligand 20 (CCL20), is also involved in pathogenesis by interacting with CCR6. The CCL20\/CCR6 axis is drawing attention as an attractive therapeutic target for various diseases. In this study, we developed novel monoclonal antibodies (mAbs) against human CCR6 (hCCR6) using the peptide immunization method, which are applicable to flow cytometry and immunohistochemistry. The established anti-hCCR6 mAb, clone C\n                    <jats:sub>6<\/jats:sub>\n                    Mab-19 (mouse IgG\n                    <jats:sub>1<\/jats:sub>\n                    , kappa), reacted with hCCR6-overexpressed Chinese hamster ovary-K1 (CHO\/hCCR6), human liver carcinoma (HepG2), and human differentiated hepatoma (HuH-7) cells in flow cytometry. The dissociation constant (\n                    <jats:italic toggle=\"yes\">K<\/jats:italic>\n                    <jats:sub>D<\/jats:sub>\n                    ) of C\n                    <jats:sub>6<\/jats:sub>\n                    Mab-19 was determined as 3.0\u2009\u00d7\u200910\n                    <jats:sup>\u221210<\/jats:sup>\n                    M for CHO\/hCCR6, 6.9\u2009\u00d7\u200910\n                    <jats:sup>\u221210<\/jats:sup>\n                    M for HepG2, and 1.8\u2009\u00d7\u200910\n                    <jats:sup>\u221210<\/jats:sup>\n                    M for HuH-7. Thus, C\n                    <jats:sub>6<\/jats:sub>\n                    Mab-19 could bind to exogenously and endogenously expressed hCCR6 with extremely high affinity. Furthermore, C\n                    <jats:sub>6<\/jats:sub>\n                    Mab-19 could stain formalin-fixed paraffin-embedded lymph node tissues from a patient with non-Hodgkin lymphoma by immunohistochemistry. Therefore, C\n                    <jats:sub>6<\/jats:sub>\n                    Mab-19 is suitable for detecting hCCR6-expressing cells and tissues and could be useful for pathological analysis and diagnosis.\n                  <\/jats:p>","DOI":"10.1089\/mab.2023.0004","type":"journal-article","created":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T12:14:34Z","timestamp":1688991274000},"page":"117-124","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Establishment of a Novel Anti-Human CCR6 Monoclonal Antibody C\n                    <sub>6<\/sub>\n                    Mab-19 with the High Binding Affinity in Flow Cytometry"],"prefix":"10.1177","volume":"42","author":[{"given":"Tomohiro","family":"Tanaka","sequence":"first","affiliation":[{"name":"Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaishi","family":"Kitamura","sequence":"additional","affiliation":[{"name":"Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika K.","family":"Kaneko","sequence":"additional","affiliation":[{"name":"Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5385-8201","authenticated-orcid":false,"given":"Yukinari","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2023,8,25]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2012.05.008"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/febs.14466"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.49"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.3390\/medicina54050088"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1124\/pharmrev.120.000011"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.23.14893"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16820-6"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S390210"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2022.06.006"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114703"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21155186"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1601815"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-022-03313-2"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024671"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-15-0732"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12010089"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2019.12.024"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.scib.2020.12.027"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1089\/mab.2021.0063"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1089\/mab.2021.0009"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1089\/mab.2021.0050"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1089\/mab.2021.0062"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1089\/mab.2021.0065"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1089\/mab.2021.0064"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1089\/mab.2022.0021"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1089\/mab.2021.0005"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1089\/mab.2022.0032"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1089\/mab.2022.0010"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1089\/mab.2022.0001"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1089\/mab.2021.0007"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1089\/mab.2022.0027"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2004.07.207"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1089\/mab.2021.0037"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.4161\/mabs.29063"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0128381"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12896-021-00699-2"},{"issue":"4","key":"e_1_3_3_38_2","first-page":"346","article-title":"Behavior of chemokine receptor 6 (CXCR6) in complex with CXCL16 soluble form chemokine by molecular dynamic simulations: General protein\u2013ligand interaction model and 3D-QSAR studies of synthetic antagonists","volume":"11","author":"Aguilera-Dur\u00e1n G","year":"2021","unstructured":"Aguilera-Dur\u00e1n G, , Romo-Mancillas A. Behavior of chemokine receptor 6 (CXCR6) in complex with CXCL16 soluble form chemokine by molecular dynamic simulations: General protein\u2013ligand interaction model and 3D-QSAR studies of synthetic antagonists. Life (Basel), 2021; 11(4):346; doi: 10.3390\/life11040346","journal-title":"Life (Basel)"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.175613"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.2174\/1871525721666230120160717"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.900916"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1068979"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.scib.2020.12.021"}],"container-title":["Monoclonal Antibodies in Immunodiagnosis &amp; Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/mab.2023.0004","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/mab.2023.0004","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/mab.2023.0004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T20:22:13Z","timestamp":1777666933000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.1089\/mab.2023.0004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["10.1089\/mab.2023.0004"],"URL":"https:\/\/doi.org\/10.1089\/mab.2023.0004","relation":{},"ISSN":["2167-9436","2167-9436"],"issn-type":[{"value":"2167-9436","type":"print"},{"value":"2167-9436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8]]}}}